WLF Decision Opens Door To Off-Label Promotion With Journal Reprints
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers can promote products for off-label uses with studies sponsored by competitors, according to the July 28 federal court decision against the FDA Modernization Act in Washington Legal Foundation v. Henney.
You may also be interested in...
Extra Caution Needed In Uncertain Period For Off-Label Info Distribution
Until FDA finalizes guidance on what practices are acceptable in distributing journal articles that describe off-label product indications, companies should watch their step in avoiding investigations that could lead to fines, criminal prosecution or exclusion from federal reimbursement programs, attorneys say
Extra Caution Needed In Uncertain Period For Off-Label Info Distribution
Until FDA finalizes guidance on what practices are acceptable in distributing journal articles that describe off-label product indications, companies should watch their step in avoiding investigations that could lead to fines, criminal prosecution or exclusion from federal reimbursement programs, attorneys say
Femtek To Seek Estrogen Indication For pHEM-ALERT Vaginal pH Test
Femtek, Inc. is hoping to build on the over-the-counter status of its pHEM-ALERT vaginal pH test by pursuing an expanded indication for the indirect measurement of estrogen levels in lieu of serum testing.